Digitized Substantiation to Be Witnessed By the Compounding Pharmacies Market

Posted by Steve Sharma on March 9th, 2022

As per Persistence Market Research’s latest revised industry analysis, the North America vet compounding pharmacies market is expected to witness high growth over the decade. The market is expected to increase from US$ 1.1 Bn in 2020 to over US$ 2.7 Bn by 2031, expanding at a CAGR of around 8.5%.

A compounded drug is a modification of its original form. The U.S. Food and Drug Administration (FDA) considers complex drugs as “Extra Label Drugs.” This means that a combination drug is a custom form of FDA-approved veterinary drug. The veterinarian’s composition must be done by either the veterinarian or the pharmacist who received the prescription from the veterinarian. Complex drugs are made on a case-by-case basis for specific patients or animals, and not in large quantities.

Demand for vet compounding pharmacies in North America is expected to be driven by increased pet adoption, rising awareness amongst pet owners, high cost of branded veterinary products, and growing preference of oral liquid formulations.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/33001

Like it? Share it!

Steve Sharma

About the Author

Steve Sharma
Joined: April 12th, 2021
Articles Posted: 444

More by this author